The Pharmacology and Mechanisms of Action of New Generation, Non-Benzodiazepine Hypnotic Agents
- 1 January 2004
- journal article
- review article
- Published by Springer Nature in CNS Drugs
- Vol. 18 (1), 9-15
- https://doi.org/10.2165/00023210-200418001-00004
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A New Benzodiazepine PharmacologyJournal of Pharmacology and Experimental Therapeutics, 2002
- Mechanism of action of the hypnotic zolpidem in vivoBritish Journal of Pharmacology, 2000
- Molecular and Neuronal Substrate for the Selective Attenuation of AnxietyScience, 2000
- ZaleplonDrugs, 2000
- Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidemEuropean Journal of Pharmacology, 1996
- Pharmacological profile of benzodiazepine site ligands with recombinant GABAA receptor subtypesEuropean Neuropsychopharmacology, 1996
- Recent developments in the behavioral pharmacology of benzodiazepine (ω) receptors: Evidence for the functional significance of receptor subtypesNeuroscience & Biobehavioral Reviews, 1994
- Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnoticsEuropean Journal of Pharmacology, 1990
- γ‐Aminobutyric AcidA Receptor α5‐Subunit Creates Novel Type II Benzodiazepine Receptor PharmacologyJournal of Neurochemistry, 1990
- Investigation of the development of tolerance to the actions of zolpidem and midazolamNeuropharmacology, 1987